ClinicalTrials.gg
RecruitingNCT07744789Updated Aug 6, 2026

Knee Ligament Stiffness Across Ethnicities Before and After Osteoarthritis Treatment

An observational study in Knee Osteoarthritis, sponsored by National Taiwan University Hospital. Recruiting at 1 site in Taiwan. Open to participants aged 20 Years and older, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-08-06.

Sponsored by National Taiwan University Hospital · Observational

How we know

From the registry’s dates

  • Started Jul 2023; still recruiting 3 years 3 months later.

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Study type
Observational
Model
Cohort
Time perspective
Prospective
Enrollment
208
Ages
20 Years and older
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-22

Among 89 studies in Osteoarthritis, Knee with a site in Taiwan — 12 open to participants now, 14 under way, 3 of them phase 3. Osteoarthritis, Knee · Taiwan.

Started
2023
with 2 others
Observational
6 of 89
3 open now
Primary completion
2027-07
later than 9 of 13 live
Registered
87th of 89
by date
Lead sponsor
4 of 89
National Taiwan University Hospital

Among the 89 studies in Osteoarthritis, Knee with a site in Taiwan, this one is one of 3 that started in 2023, is one of 6 observational ones, reaches primary completion later than 9 of the 13 other live ones, and was the 87th registered.

Osteoarthritis, Knee

3,297 studies on the registry are indexed under Osteoarthritis, Knee; 623 are open to participants now.

Browse Osteoarthritis, Knee studies →

Open to participants now

12 of the 89 studies in Osteoarthritis, Knee with a site in Taiwan are open now. Recruiting first, the newest first:

6 more — sign in →

All 12 open studies →

A study can be open while its sites in Taiwan have not opened yet or have stopped. Only those recruiting at a site in Taiwan →

Who these studies take

Of the 384 Osteoarthritis, Knee studies recruiting now, 178 (46%) set no upper age limit and 113 (29%) stop at 75 or younger; 19 take children under 18; 39 take healthy volunteers.

This study: 20 Years and older · all sexes · healthy volunteers too.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 89 studies in Osteoarthritis, Knee with a site in Taiwan, or all of them as a file.
02

Study summary

This prospective clinical study aims to establish normative values of knee ligament stiffness across different ethnic populations using shear wave elastography (SWE) and to investigate biomechanical alterations associated with knee osteoarthritis (OA). Healthy adults and patients with symptomatic knee OA will undergo standardized SWE examinations of the anterior cruciate ligament (ACL), posterior cruciate ligament (PCL), medial collateral ligament (MCL), and lateral collateral ligament (LCL), together with clinical assessments. For patients who subsequently receive clinically indicated ultrasound-guided injection therapy, follow-up SWE and clinical evaluations will be performed to investigate changes in ligament stiffness after treatment.

Read the detailed description

Knee osteoarthritis is increasingly recognized as a whole-joint disease involving not only articular cartilage but also periarticular soft tissues, including the cruciate and collateral ligaments. Although ultrasound elastography has been widely applied to musculoskeletal tissues, normative biomechanical data for knee ligaments remain limited, and the influence of osteoarthritis on ligament stiffness has not been fully characterized.

The primary objective of this study is to establish normative shear wave elastography values for the ACL, PCL, MCL, and LCL across different age groups and ethnic populations and to determine their associations with demographic characteristics, body composition, and limb dominance. A secondary objective is to compare ligament stiffness between healthy individuals and patients with radiographic knee osteoarthritis. Participants will undergo standardized ultrasound examinations, SWE measurements, physical examinations, pain assessment using the Visual Analog Scale (VAS), and functional assessment using the Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC).

Patients with symptomatic knee osteoarthritis will initially receive conservative treatment according to routine clinical practice. Those who subsequently undergo clinically indicated ultrasound-guided injection therapy, including corticosteroid, hypertonic dextrose prolotherapy, or platelet-rich plasma (PRP), will receive repeat clinical and SWE evaluations after completion of treatment to investigate longitudinal changes in ligament biomechanical properties. The study will also assess measurement reliability through intra- and inter-rater analyses.

03

Conditions studied

  • Knee Osteoarthritis

Keywords

  • Knee Osteoarthritis
  • Shear Wave Elastography
  • Anterior Cruciate Ligament
  • Posterior Cruciate Ligament
  • Medial Collateral Ligament
  • Lateral Collateral Ligament
  • Ultrasound
04

Who can participate

Ages eligible
20 Years and older
Sexes eligible
All
Accepts healthy volunteers
Yes
Sampling method
Non-probability sample

Study population

Healthy adult volunteers and adults with symptomatic radiographic knee osteoarthritis recruited from the outpatient Department of Physical Medicine and Rehabilitation at National Taiwan University Hospital, Bei-Hu Branch. Healthy participants are enrolled to establish normative knee ligament stiffness values, whereas patients with knee osteoarthritis undergo clinical assessment, shear wave elastography, and, when clinically indicated, follow-up evaluation after ultrasound-guided injection therapy.

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Healthy volunteers:
  • Adults aged 20 years or older.
  • Able to understand the study procedures and provide written .
  • Able to ambulate independently without walking aids.
  • No pain in either knee during the previous 6 months.
  • Patients with symptomatic knee osteoarthritis:
  • Adults aged 20 years or older.
  • Able to understand the study procedures and provide written informed consent.
  • Pain in at least one knee during the previous year.
  • Knee pain, soreness, or stiffness documented within the previous month.
  • Radiographic knee osteoarthritis defined by at least one of the following:
  • Kellgren-Lawrence grade ≥2 on anteroposterior radiographs.
  • Kellgren-Lawrence grade ≥2 on skyline radiographs.
  • Superior or inferior patellar osteophytes or posterior tibial osteophytes on lateral radiographs.

Exclusion criteria

Exclusion Criteria

  • Healthy volunteers:
  • Previous knee surgery.
  • Rupture of any cruciate or collateral ligament.
  • Major knee or periarticular trauma.
  • Rheumatic or disease.
  • Diagnosis of knee osteoarthritis within the previous 6 months.
  • Patients with symptomatic knee osteoarthritis:
  • Rheumatic or autoimmune disease.
  • .
  • Previous major knee trauma or knee surgery.
  • injection into the affected knee within the previous 3 months.
Terms in these criteria, in plain language(4)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Informed consent

Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.

You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.

Autoimmune disease

A condition in which the immune system attacks the body’s own tissues, such as rheumatoid arthritis, lupus, psoriasis, type 1 diabetes or inflammatory bowel disease.

Immunotherapy studies often leave out active autoimmune disease, and some name exceptions, such as thyroid disease on replacement hormone. Check the exceptions this study lists.

Cancer (malignancy)

Malignancy means cancer. Criteria about another or earlier malignancy ask whether you have had a different cancer, usually within a set number of years.

Some are commonly allowed, such as treated skin cancers other than melanoma and early cancers removed completely — check the exceptions this study lists.

Corticosteroids (steroids)

Anti-inflammatory medicines such as prednisone, prednisolone and dexamethasone — not the anabolic steroids used for muscle.

Studies differ in what they allow: check which steroid medicines, routes (tablets, injections, creams, inhalers, eye drops) and doses this study accepts.

05

Study design

Observational model
Cohort
Time perspective
Prospective
Enrollment
208 participants (estimated)
Target follow-up
1 Month
Patient registry
Yes

Groups and cohorts

  • Healthy Controls

    Healthy adults without knee pain or major systemic disease undergoing standardized clinical assessment and bilateral knee ligament shear wave elastography.

    Procedure: Shear Wave Elastography

  • Symptomatic Knee Osteoarthritis

    Adults with symptomatic radiographic knee osteoarthritis undergoing baseline clinical assessment, physical examination, and bilateral knee ligament shear wave elastography.

    Procedure: Shear Wave Elastography

  • Knee Osteoarthritis After Injection Therapy

    Participants with symptomatic knee osteoarthritis who subsequently receive clinically indicated ultrasound-guided injection therapy and undergo follow-up clinical and shear wave elastography assessments after treatment.

    Procedure: Shear Wave Elastography · Procedure: Ultrasound-Guided Injection Therapy

Interventions

  • ProcedureShear Wave Elastography

    Bilateral shear wave elastography of the anterior cruciate ligament, posterior cruciate ligament, medial collateral ligament, and lateral collateral ligament was performed to quantify ligament stiffness.

  • ProcedureUltrasound-Guided Injection Therapy

    Ultrasound-guided ligament injection using corticosteroid, hypertonic dextrose, or platelet-rich plasma according to clinical indication.

06

What researchers measure

Primary outcomes

  1. Knee Ligament Stiffness Measured by Shear Wave Elastography

    Shear wave velocity (m/s) of the anterior cruciate ligament (ACL), posterior cruciate ligament (PCL), medial collateral ligament (MCL), and lateral collateral ligament (LCL) measured using standardized shear wave elastography.

    Time frame: Baseline

Secondary outcomes

  1. Pain Intensity

    Pain intensity assessed using the Visual Analog Scale (VAS). The VAS ranges from 0 to 10, where 0 indicates no pain and 10 indicates the worst imaginable pain. Higher scores indicate greater pain severity.

    Time frame: Baseline

  2. Physical Function

    Physical function assessed using the Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC). The WOMAC consists of 24 items evaluating pain, stiffness, and physical function. Each item is scored on a 0-10 visual analog scale, with higher scores indicating greater pain, stiffness, and functional impairment. The total WOMAC score ranges from 0 to 240, with higher scores indicating worse symptoms and poorer physical function.

    Time frame: Baseline

07

Study locations

1 of 1 sites recruiting
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Started Jul 2023 (actual). Primary completion is estimated for Jul 2027, 47 months after the start.

Of 179 non-industry observational studies under Osteoarthritis, Knee, half reached primary completion within 24 months of starting (the median), counting those still running; a quarter within 12 and three quarters within 48. This study's planned 47 months is above that.

Counting every sponsor, half of 220 studies reached it within 24 months; a quarter within 13 and three quarters within 61.

How these figures are worked out, and which studies are left out of them.

Registered
Jul 27, 2026
First posted
Aug 4, 2026
StartActual
Jul 26, 2023
Primary completionEst.
Jul 1, 2027
CompletionEst.
Dec 1, 2027
Last update
Aug 6, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Aug 6, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT07744789
Collaborators
National Taiwan University Hospital Beihu Branch
Responsible party
Sponsor
First posted
Aug 4, 2026
Start date
Jul 26, 2023
Primary completion
Jul 1, 2027 (estimated)
Completion
Dec 1, 2027 (estimated)
Last update
Aug 6, 2026

Study contacts

Ke-Vin Chang, MD, PhD
Contact
kvchang011@gmail.com
+886-2-23717101
Wei-Ting Wu, MD
Contact
wwtaustin@yahoo.com.tw
+886-2-23717101

Oversight

FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion